Clariant AG (CLN.SW)
Clariant AG (CLN.SW) Stock Price, Analysis & Data
| Bid | n/a |
| Market Cap | 3.58B |
| Revenue (ttm) | 3.79B |
| Net Income (ttm) | -31.1M |
| Beta | 0.48 |
| EPS (ttm) | -0.1 |
| PE Ratio (ttm) | n/a |
| Forward PE | 12.71 |
| P/B (ttm) | 1.78 |
| P/S (ttm) | 0.94 |
| Earnings Date | Feb 23, 2027 |
| Ask | n/a |
| Volume | 654,417 |
| Avg. Volume (20D) | 1,135,008 |
| Open | 10.73 |
| Previous Close | 10.83 |
| Day's Range | 10.70 - 10.90 |
| 52-Week Range | 6.55 - 11.04 |
| Analyst | Buy |
| Price Target | 10.75 (-1.19%) |
| Dividends | $0.42 (3.88%) |
| Ex-Dividend Date | Jun 2, 2026 |
About CLN.SW
Clariant AG develops, manufactures, distributes, and sells specialty chemicals in Switzerland, Europe, the Middle East, Africa, the United States, and the Asia Pacific. It operates through Care Chemicals, Catalysts, and Adsorbents & Additives segments. The Care Chemicals segment offers personal and home care, crop solutions, industrial applications, base chemicals, oil services, and mining solutions for various applications in home and personal c...
Financial Performance
In 2025, Clariant's revenue was 3.92B, a decrease of -5.71% compared to the previous year's 4.15B. Earnings were -75M, a decrease of -130.74%.
Financial numbers in CHF Financial StatementsAnalyst Forecast
According to 16 analyst ratings, the average rating for CLN.SW stock is "Buy". The 12-month stock price forecast is 10.75, which is downside of 1.19% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
